Frontlight ResearchEarly access
Retinitis pigmentosa trials in Spain
1 trial · From EU CTIS (euclinicaltrials.eu), checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 3Not yet taking people in SpainA Phase 1/2/3 Study of ATSN-201 Gene Therapy in Subjects with RS1-Associated X linked Retinoschisis
- Where
- Esplugues de Llobregat, Madrid
- People
- 36 worldwide
- Run by
- Atsena Therapeutics Inc.
See details and how to joinNCT05878860 · EU 2026-525886-38-00